1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Relapsed Angioimmunoblastic T-Cell Lymphoma: new trials by email Literature Review of Relapsed Angioimmunoblastic T-Cell Lymphoma trials Research Report on Relapsed Angioimmunoblastic T-Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL Oral azacitidine, Romidepsin, Bendamustine - Relapsed Angioimmunoblastic T-Cell Lymphoma, Refractory Angioimmunoblastic T-cell Lymphoma | Phase 3 | Completed | The Lymphoma Academic Research Organisation | 86 | 2018-11-09 | 2026-04-23 |
Immunoblastic Lymphadenopathy (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphadenopathy (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1)
Azacitidine (1) · Bendamustine Hydrochloride (1) · Gemcitabine (1) · cc-486 (1) · romidepsin (1)
The Lymphoma Academic Research Organisation (1)
Austria (1) · Belgium (1) · Denmark (1) · France (1) · United Kingdom (1)